Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

CAR T-cell therapy uses your own immune cells to fight cancer in a new way. It changes immune cells called T cells so they target tumors directly. It’s been approved to treat certain types of ...

Transformative research introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy. At EPFL's School of Engineering ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells - a type of cancer immunotherapy - that can be switched on to varying degrees of intensity and ...

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel like they have "brain fog," or forgetfulness and difficulty concentrating.

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR molecules can be transferred from the CAR-T cells ...

For decades, immunologists have explored CAR-T cell therapy as an effective tool to fight blood cancer. Increasingly, CAR-T cells are being explored as a potential silver bullet for treating ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

At its core, CAR-T therapy involves modifying T-cells to target and eliminate specific cancer cells. These modified T-cells are equipped with Chimeric Antigen Receptors (CARs) that allow them to ...